• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Molecular Diagnostics Market

United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020


The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. The United States is the key market for molecular diagnostics due to the availability of government funds, rising incidence of chronic diseases, the availability of different types of tests, and high awareness of pharmacogenomics/personalized medicine. Moreover, major companies have easy access to United States which makes the United States the largest and most significant market for suppliers.  


United States Molecular Diagnostics Market and Test Volume - Application Segment Analysis: In United States molecular diagnostic market, infectious disease controls the maximum share of the market. Molecular oncology tests have emerged as a significant rapidly growing market segment. Increased public awareness of the relationship between genetics and personal health has increased the demand for molecular genetic testing. The genetic testing is the third leading segment of the molecular diagnostics market followed by the blood screening test market. Molecular diagnostics is also gaining popularity as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.


United States is the major food safety testing market. The food pathogen test volume accounts for the maximum share of the molecular diagnostics volume. The infectious disease at the second spot in molecular diagnostics application test volume with nearly XX% volume share in 2014.  The oncology testing stands at the third spot in molecular diagnostics test volume followed by the blood screening test. Genetic testing and HLA tests are also gaining popularity in the molecular diagnostics landscape.




United States Molecular Diagnostics Market - Company Analysis: In the United States molecular diagnostics market, Hologic Inc. captures the maximum share of the market. Myriad Genetics holds the second position in the United States molecular diagnostics market being followed by Roche. In 2014, Molecular Diagnostics accounted for 50% of Qiagen total sales. In 2015, Cepheid is anticipated to extend the market segment reach with entry into the CLIA-waived testing market in the US. 

iGATE RESEARCH report titled “United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020” is a 130 page report with 87 Figures. This report studies in detail the United States Molecular Diagnostics Market and Test Volume, United States Molecular Diagnostics Company Sales Analysis along with the Driving Factors and Challenges for the United States Molecular Diagnostics Market.   

The United States Molecular Diagnostics Market has been analysed from 4 View Points:

1) United States - Molecular Diagnostics Market and Forecast 
2) United States Molecular Diagnostics Market - Application Segment Analysis
3) United States Molecular Diagnostics Market - Application Segment Test Volume Analysis
4) United States Molecular Diagnostics Market - Company Sales Analysis  

United States Molecular Diagnostics Market and Test Volume - Application Segment Analysis (2010 - 2020)

1. Oncology Testing 
a) Breast Cancer
b) Colorectal Cancer
c) Prostate Cancer
d) Others

2. Infectious Diseases
a) Virology Testing
b) HPV Testing
c) HAI Testing
d) Critical Care Testing

3. Genetic Testing
4. Blood Screening
5. Food  Pathogen Testing
6. Tissue Typing (HLA Testing)


United States Molecular Diagnostics - Company Sales Analysis (2010 - 2020)

1. Roche
2. Abbott
3. Myriad Genetics
4. BioMerieux
5. Qiagen
6. Hologic Inc.
7. Becton Dickinson
8. Siemens
9. Cepheid
10.  Others


Source of Information


iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.	
1. Executive Summary

2. United States - Molecular Diagnostics Market, Test Volume and Forecast (2010 - 2020) 

2.1 United States - Molecular Diagnostics Market and Forecast
2.2 United States - Molecular Diagnostics Test Volume and Forecast

3. United States - Molecular Diagnostics Market and Volume Share (2010 - 2020)

3.1 United States - Application Wise Molecular Diagnostics Market Share and Forecast
3.2 United States - Company Wise Molecular Diagnostics Market Share and Forecast
3.3 United States Molecular Diagnostics Test Volume Share and Forecast - Application Wise

4. United States Molecular Diagnostics Market and Forecast - Application Wise

4.1 Oncology Testing Market (2004 - 2020)

4.1.1 Breast Cancer Testing Market (2004 - 2020) 
4.1.2 Colorectal Cancer Testing Market (2004 - 2020) 
4.1.3 Prostate Cancer Testing Market (2004 - 2020) 
4.1.4 Other Cancer Testing Market (2004 - 2020) 

4.2 Infectious Disease Testing Market (2010 - 2020) 

4.2.1 Virology Testing Market (2007 - 2020) 
4.2.2 HPV Testing Market (2004 - 2020) 
4.2.3 HAI Testing Market (2010 - 2020) 
4.2.4 Critical Care Testing Market (2010 - 2020) 

4.3 Genetic Testing Market (2010 - 2020) 
4.4 Blood Screening Market (2006 - 2020) 
4.5 Food Pathogen Testing Market (2010 - 2020) 
4.6 Tissue Typing (HLA) Testing Market (2008 - 2020) 

5. United States Molecular Diagnostics Test Volume - Application Wise

5.1 Oncology Test Volume (2004 - 2020)

5.1.1 Breast Cancer Test Volume (2004 - 2020) 
5.1.2 Colorectal Cancer Test Volume (2004 - 2020) 
5.1.3 Prostate Cancer Test Volume (2004 - 2020) 
5.1.4 Other Cancer Test Volume (2004 - 2020)

5.2 Infectious Disease Test Volume (2010 - 2020)

5.2.1 Virology Test Volume (2007 - 2020) 
5.2.2 HPV Test Volume (2004 - 2020) 
5.2.3 HAI Test Volume (2010 - 2020) 
5.2.4 Critical Care Test Volume (2010 - 2020)

5.3 Genetic Testing Test Volume and Forecast (2010 - 2020) 
5.4 Blood Screening Test Volume and Forecast (2006 - 2020) 
5.5 Food Pathogen Test Volume and Forecast (2010 - 2020) 
5.6 HLA Test Volume and Forecast (2008 - 2020)

6. United States Molecular Diagnostics Market -   Company Wise

6.1 Roche - United States Molecular Diagnostic Sales and Forecast
6.2 Abbott Laboratories - United States Molecular Diagnostic Sales and Forecast
6.3 Myriad Genetics - United States Molecular Diagnostic Sales and Forecast
6.4 Biomerieux - United States Molecular Diagnostic Sales and Forecast
6.5 Qiagen - United States Molecular Diagnostic Sales and Forecast
6.6 Hologic Inc. (Acquired Gen-Probe) - United States Molecular Diagnostic Sales and Forecast
6.7 Becton Dickinson - United States Molecular Diagnostic Sales and Forecast
6.8 Siemens - United States Molecular Diagnostic Sales and Forecast
6.9 Cepheid - United States Molecular Diagnostic Sales and Forecast
6.10 Others - United States Molecular Diagnostic Sales and Forecast

7. United States Molecular Diagnostics Market - Driving Factors

7.1 Increasing Automation to Drive the Molecular Diagnostics Market
7.2 Investment in Genomics and Proteomics Research
7.3 Personalized Medicine Fuels Molecular Diagnostics

8. United States Molecular Diagnostics Market - Challenges

8.1 Regulatory Issues
8.2 Reimbursement Capabilities
8.3 Quality Checkpoints, Awareness and Acceptance

	List of Figures:

Figure 2-1: United States - Molecular Diagnostics Market (Million US$), 2010 - 2014
Figure 2-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2015 - 2020
Figure 2-3: United States - Molecular Diagnostics Test Volume (Million), 2010 - 2014
Figure 2-4: United States - Forecast for Molecular Diagnostics Test Volume (Million), 2015 - 2020

Figure 3-1: United States - Molecular Diagnostics Applications Market Share (Percent), 2010 - 2014
Figure 3-2: United States - Forecast for Molecular Diagnostics Applications Market Share (Percent), 2015 - 2020
Figure 3-3: United States - Company Wise Molecular Diagnostics Market Share (Percent), 2010 - 2014
Figure 3-4: United States - Forecast for Company Wise Molecular Diagnostics Market Share (Percent), 2015 - 2020
Figure 3-5: United States - Molecular Diagnostics Applications Test Volume Share (Percent), 2010 - 2014
Figure 3-6: United States - Forecast for Molecular Diagnostics Applications Test Volume Share (Percent), 2015 - 2020

Figure 4-1: United States - Molecular Diagnostic Oncology Testing Market (Million US$), 2004 - 2014
Figure 4-2: United States - Forecast for Molecular Diagnostic Oncology Testing Market (Million US$), 2015 - 2020
Figure 4-3: United States - Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-4: United States - Forecast for Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-5: United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-6: United States - Forecast for Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-7: United States - Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-8: United States - Forecast for Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-9: United States - Other Molecular Diagnostic Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-10: United States - Forecast for Other Molecular Diagnostic Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-11: United States - Infectious Disease Testing Market (Million US$), 2010 - 2014
Figure 4-12: United States - Forecast for Infectious Disease Testing Market (Million US$), 2015 - 2020
Figure 4-13: United States - Virology Testing Market (Million US$), 2007 - 2014
Figure 4-14: United States - Forecast for Virology Testing Market (Million US$), 2015 - 2020
Figure 4-15: United States - HPV Testing Market (Million US$), 2004 - 2014
Figure 4-16: United States - Forecast for HPV Testing Market (Million US$), 2015 - 2020
Figure 4-17: United States - HAI Testing Market (Million US$), 2010 - 2014
Figure 4-18: United States - Forecast for HAI Testing Market (Million US$), 2015 - 2020
Figure 4-19: United States - Critical Care Testing Market (Million US$), 2010 - 2014
Figure 4-20: United States - Forecast for Critical Care Testing Market (Million US$), 2015 - 2020
Figure 4-21: United States - Genetic Testing Market (Million US$), 2010 - 2014
Figure 4-22: United States - Forecast for Genetic Testing Market (Million US$), 2015 - 2020
Figure 4-23: United States - Blood Screening Market (Million US$), 2006 - 2014
Figure 4-24: United States - Forecast for Blood Screening Market (Million US$), 2015 - 2020
Figure 4-25: United States - Food Pathogen Testing Market (Million US$), 2010 - 2014
Figure 4-26: United States - Forecast for Food Pathogen Testing Market (Million US$), 2015 - 2020
Figure 4-27: United States - HLA Testing Market (Million US$), 2008 - 2014
Figure 4-28: United States - Forecast for HLA Testing Market (Million US$), 2015 - 2020

Figure 5-1: United States - Oncology Test Volume (Million), 2004 - 2014
Figure 5-2: United States - Forecast for Oncology Test Volume (Million), 2015 - 2020
Figure 5-3: United States - Breast Cancer Test Volume (Million), 2004 - 2014
Figure 5-4: United States - Forecast for Breast Cancer Test Volume (Million), 2015 - 2020
Figure 5-5: United States - Colorectal Cancer Test Volume (Million), 2004 - 2014
Figure 5-6: United States - Forecast for Colorectal Cancer Test Volume (Million), 2015 - 2020
Figure 5-7: United States - Prostate Cancer Test Volume (Million), 2004 - 2014
Figure 5-8: United States - Forecast for Prostate Cancer Test Volume (Million), 2015 - 2020
Figure 5-9: United States - Other Cancer Test Volume (Million), 2004 - 2014
Figure 5-10: United States - Forecast for Other Cancer Test Volume (Million), 2015 - 2020
Figure 5-11: United States - Infectious Disease Test Volume (Million), 2010 - 2014
Figure 5-12: United States - Forecast for Infectious Disease Test Volume (Million), 2015 - 2020
Figure 5-13: United States - Virology Test Volume (Million), 2007 - 2014
Figure 5-14: United States - Forecast for Virology Test Volume (Million), 2015 - 2020
Figure 5-15: United States - HPV Test Volume (Million), 2004 - 2014
Figure 5-16: United States - Forecast for HPV Test Volume (Million), 2015 - 2020
Figure 5-17: United States - HAI Test Volume (Million), 2010 - 2014
Figure 5-18: United States - Forecast for HAI Test Volume (Million), 2015 - 2020
Figure 5-19: United States - Critical Care Test Volume (Million), 2010 - 2014
Figure 5-20: United States - Forecast for Critical Care Test Volume (Million), 2015 - 2020
Figure 5-21: United States - Genetic Testing Test Volume (Million), 2010 - 2014
Figure 5-22: United States - Forecast for Genetic Testing Test Volume (Million), 2015 - 2020
Figure 5-23: United States - Blood Screening Test Volume (Million), 2006 - 2014
Figure 5-24: United States - Forecast for Blood Screening Test Volume (Million), 2015 - 2020
Figure 5-25: United States - Food Pathogen Test Volume (Million), 2010 - 2014
Figure 5-26: United States - Forecast for Food Pathogen Test Volume (Million), 2015 - 2020
Figure 5-27: United States - HLA Test Volume (Million), 2008 - 2014
Figure 5-28: United States - Forecast for HLA Test Volume (Million), 2015 - 2020

Figure 6-1: Roche - United States Molecular Diagnostic Sales (Million US$), 2008 - 2014
Figure 6-2: Roche - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-3: Abbott Laboratories - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-4: Abbott Laboratories - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-5: Myriad Genetics - United States Molecular Diagnostic Sales (Million US$), 2007 - 2014
Figure 6-6: Myriad Genetics - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-7: Biomerieux - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-8: Biomerieux - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-9: Qiagen - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-10: Qiagen - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-11: Hologic-Gen-Probe - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-12: Hologic-Gen-Probe - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-13: Becton Dickinson - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-14: Becton Dickinson - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-15: Siemens - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-16: Siemens - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-17: Cepheid - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-18: Cepheid - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-19: Others - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-20: Others - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020

Figure 7-1: United States - Investment in the Human Genome Project (Billion US$), 2003, 2012

Related Reports

SPG-Microstimulator-System-Market

Global SPG Microstimulator System Market Professional Survey Report 2019

SPG Microstimulator System is indicated for pain relief in cluster headache (CH) and migraine in patients for whom standard treatment is not adequate or contraindicated.  The global SPG Microstimula ...read more

Regenerative-Artificial-Skin-Market

Global Regenerative Artificial Skin Market Professional Survey Report 2019

Artificial skin are generally prepared from collagen which is easily resorbed by body helps to generate the new skin on the affected part. Continuous research are carried out by various companies to d ...read more

Preclinical-CRO-Market

Global Preclinical CRO Market Professional Survey Report 2019

A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical co ...read more

Neurodegenerative-Disease-Market

Global Neurodegenerative Disease Market Professional Survey Report 2019

Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventua ...read more

Medication-Management-System-Market

Global Medication Management System Market Professional Survey Report 2019

Medication management systems ensure tracking and validation of the medication administered to patients at all points of care. These systems help healthcare organizations to minimize medical errors oc ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Intel Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.